Therapy Areas: Oncology
18 January 2018 - - The Woodbury, New York-based pancreatic research funding organization Lustgarten Foundation funded USD 22m in 2017 as part of its commitment to invest USD 40m by the end of 2018, t...
18 January 2018 - - Washington, DC-based immuno-oncology biotechnology company GT Biopharma Inc. (OTCQB: GTBP) (Euronext Paris: GTBP.PA) has appointed Geoffrey B. Davis to its board of directors, effe...
18 January 2018 - - Vancouver, British Columbia-based prostate cancer treatment developer ESSA Pharma Inc. (TSXV: EPI; NASDAQ: EPIX) has closed the second tranche of its brokered equity offering, rais...
18 January 2018 - United States-based Merck's Keytruda (pembrolizumab) in combination with pemetrexed (Alimta) plus platinum chemotherapy has improved overall survival and progression-free surviv...
18 January 2018 - Moleculin Biotech Inc, (NASDAQ: MBRX), a clinical stage pharmaceutical company focused on the development of anti-cancer drug candidates, has added Dr Jorge Cortes and Dr Elihu Estey...
18 January 2018 - Human therapeutics company Amgen (NASDAQ:AMGN) reported on Wednesday the receipt of approval from the US Food and Drug Administration (FDA) to add the supplemental New Drug Applicati...